Home Clovis

Clovis

In operation
IPO Delisting
Biopharmaceutical Manufacturer
Basic
Enterprise Profile

Basic Information

Clovis Oncology is a biopharmaceutical company focused on acquiring, developing, and commercializing cancer treatments in the United States, Europe, and other international markets. Their development programs target specific cancer subtypes, combining precision medicine with companion diagnostics to guide treatment for patients most likely to benefit.
Clovis Oncology, Inc.
Colorado,United States of America
101~500 people
January 01, 2009
businessdevelopment@clovisoncology.com.

Enterprise Profile

Industrial Sector
New Drug Development
Technology
Gene Technology Biotechnology
Concept
Disease Treatment Ovarian Cancer Prostate Cancer
Application Scenarios
Innovative Drugs